Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
AMPH Amphastar Pharmaceuticals, Inc. daily Stock Chart
AMPH [NASD]
Amphastar Pharmaceuticals, Inc.
Healthcare | Drug Manufacturers - Other | USA
statements
Index- P/E15.10 EPS (ttm)0.98 Insider Own5.90% Shs Outstand46.20M Perf Week5.12%
Market Cap682.84M Forward P/E12.16 EPS next Y1.22 Insider Trans-3.19% Shs Float35.23M Perf Month-5.92%
Income48.90M PEG0.60 EPS next Q0.09 Inst Own54.90% Short Float8.36% Perf Quarter-21.76%
Sales322.40M P/S2.12 EPS this Y892.90% Inst Trans0.11% Short Ratio11.66 Perf Half Y-24.65%
Book/sh8.14 P/B1.82 EPS next Y113.53% ROA8.40% Target Price21.75 Perf Year-30.64%
Cash/sh1.85 P/C8.00 EPS next 5Y25.00% ROE13.10% 52W Range12.32 - 23.06 Perf YTD-23.38%
Dividend- P/FCF3414.18 EPS past 5Y42.40% ROI-3.20% 52W High-35.91% Beta1.08
Dividend %- Quick Ratio1.60 Sales past 5Y8.90% Gross Margin40.90% 52W Low19.92% ATR1.04
Employees2027 Current Ratio2.80 Sales Q/Q-7.00% Oper. Margin0.00% RSI (14)48.42 Volatility6.82% 7.70%
OptionableYes Debt/Eq0.12 EPS Q/Q-154.30% Profit Margin15.20% Rel Volume0.87 Prev Close14.77
ShortableYes LT Debt/Eq0.10 EarningsMar 12 AMC Payout0.00% Avg Volume252.63K Price14.78
Recom2.50 SMA204.69% SMA50-11.87% SMA200-22.90% Volume220,552 Change0.07%
Mar-13-19Downgrade Piper Jaffray Overweight → Neutral $24 → $23
Mar-13-19Downgrade Needham Buy → Hold
Aug-10-18Reiterated Needham Buy $24 → $22
Mar-13-18Reiterated Needham Buy $23 → $24
Dec-01-17Reiterated Needham Buy $20 → $23
Nov-09-17Downgrade Raymond James Outperform → Mkt Perform
Sep-27-17Reiterated Needham Buy $18 → $20
Mar-14-17Downgrade Raymond James Strong Buy → Outperform
Aug-09-16Reiterated Needham Buy $20 → $22
May-10-16Reiterated Needham Buy $21 → $20
Feb-19-16Initiated Wells Fargo Outperform
Jun-19-15Reiterated Needham Buy $17 → $21
Jun-03-15Initiated Raymond James Strong Buy
Jul-21-14Initiated Needham Buy $17
Mar-31-20 10:56AM  Edited Transcript of AMPH earnings conference call or presentation 12-Mar-20 9:00pm GMT Thomson Reuters StreetEvents
Mar-29-20 08:36AM  Is Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) CEO Pay Justified? Simply Wall St.
Mar-25-20 09:33AM  Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress Zacks
Mar-24-20 09:47AM  What Bargain Hunting? Tap 5 Stocks With Rising P/E Zacks
Mar-20-20 10:44AM  Generic Drugs Industry's Prospects Uncertain Amid Coronavirus Zacks -5.17%
Mar-12-20 06:05PM  Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Beat Estimates Zacks -9.35%
04:05PM  Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2019 GlobeNewswire
03:00PM  Amphastar Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-05-20 04:05PM  Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12th, 2020 GlobeNewswire
Mar-03-20 12:30PM  Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for Zacks
Feb-27-20 06:00AM  Amphastar Pharmaceuticals Receives FDA Approval for Supplement to its Abbreviated New Drug Application for Sodium Bicarbonate Injection, USP 8.4%, 50mEq/50mL GlobeNewswire
Feb-13-20 05:48AM  Amphastar Pharmaceuticals (NASDAQ:AMPH) Could Easily Take On More Debt Simply Wall St.
Jan-29-20 08:30AM  The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut Benzinga
Jan-28-20 04:05PM  Amphastar Announces the Receipt of a MINOR CRL for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial GlobeNewswire
Jan-08-20 05:15AM  Can You Imagine How Amphastar Pharmaceuticals's (NASDAQ:AMPH) Shareholders Feel About The 54% Share Price Increase? Simply Wall St.
Dec-17-19 07:19PM  Here is What Hedge Funds Think About Amphastar Pharmaceuticals Inc (AMPH) Insider Monkey
Dec-10-19 10:25PM  Edited Transcript of AMPH earnings conference call or presentation 7-Nov-19 10:00pm GMT Thomson Reuters StreetEvents
Dec-02-19 05:16AM  Based On Its ROE, Is Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) A High Quality Stock? Simply Wall St.
Nov-27-19 06:00AM  Amphastar Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-15-19 06:00AM  Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference GlobeNewswire
Nov-07-19 04:05PM  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2019 GlobeNewswire
Nov-01-19 06:00AM  Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 7th, 2019 GlobeNewswire
Oct-28-19 02:14PM  Is Amphastar Pharmaceuticals Inc (AMPH) A Good Stock To Buy? Insider Monkey
Oct-21-19 06:17AM  How Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Can Impact Your Portfolio Volatility Simply Wall St.
Sep-21-19 07:58AM  How Much Did Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) CEO Pocket Last Year? Simply Wall St.
Sep-12-19 09:15PM  Amphastar Pharmaceuticals Inc (AMPH) CEO & Chief Scientific Officer Jack Y. Zhang Sold $6. ... GuruFocus.com
Sep-01-19 09:38PM  Edited Transcript of AMPH earnings conference call or presentation 7-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
Aug-29-19 06:01AM  Amphastar Pharmaceuticals to Present at the Wells Fargo 2019 Healthcare Conference GlobeNewswire
Aug-22-19 08:44AM  Does Amphastar Pharmaceuticals (NASDAQ:AMPH) Have A Healthy Balance Sheet? Simply Wall St.
Aug-07-19 11:24PM  Amphastar Pharmaceuticals Inc (AMPH) Q2 2019 Earnings Call Transcript Motley Fool
08:55PM  Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates Zacks
04:05PM  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2019 GlobeNewswire
Aug-05-19 06:00AM  Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2019 GlobeNewswire
Jul-23-19 01:19PM  Should You Be Holding Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)? Simply Wall St.
Jun-29-19 06:18PM  Is Amphastar Pharmaceuticals Inc (AMPH) A Good Stock To Buy ? Insider Monkey
Jun-24-19 06:00AM  Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference GlobeNewswire
Jun-19-19 06:00AM  Amphastar Pharmaceuticals, Inc. Announces Settlement in Litigation with Momenta and Sandoz GlobeNewswire
Jun-14-19 02:07PM  Introducing Amphastar Pharmaceuticals (NASDAQ:AMPH), A Stock That Climbed 33% In The Last Three Years Simply Wall St.
06:00AM  Amphastar Pharmaceuticals to Present at the Raymond James Life Sciences and MedTech Healthcare Conference GlobeNewswire
May-31-19 06:00AM  Amphastar Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference GlobeNewswire
May-28-19 02:47PM  7 Stocks to Buy for June InvestorPlace
May-21-19 01:33AM  Edited Transcript of AMPH earnings conference call or presentation 9-May-19 9:00pm GMT Thomson Reuters StreetEvents
May-10-19 06:00AM  Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference 2019 GlobeNewswire
12:24AM  Amphastar Pharmaceuticals Inc (AMPH) Q1 2019 Earnings Call Transcript Motley Fool
May-09-19 07:05PM  Amphastar Pharmaceuticals (AMPH) Q1 Earnings and Revenues Surpass Estimates Zacks
05:58PM  Amphastar: 1Q Earnings Snapshot Associated Press
04:05PM  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2019 GlobeNewswire
May-07-19 10:56AM  Heres What Hedge Funds Think About Amphastar Pharmaceuticals Inc (AMPH) Insider Monkey
May-06-19 06:00AM  Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2019 GlobeNewswire
May-01-19 10:33AM  Amphastar Pharmaceuticals (AMPH) to Report Q1 Results: Wall Street Expects Earnings Growth Zacks
Apr-26-19 09:30AM  MNK or AMPH: Which Is the Better Value Stock Right Now? Zacks
Apr-25-19 03:13PM  Do Insiders Own Shares In Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)? Simply Wall St.
Apr-15-19 09:30AM  Small Cap Pot Stocks Can Bring Investors High Profits-THC Therapeutics, Inc. ACCESSWIRE
Apr-10-19 09:30AM  MNK vs. AMPH: Which Stock Is the Better Value Option? Zacks
Mar-26-19 05:32PM  Amid talk of buyout, Peninsula biotech zeroes in on its blood-thinner antidote American City Business Journals
Mar-25-19 09:30AM  MNK vs. AMPH: Which Stock Should Value Investors Buy Now? Zacks
Mar-21-19 12:06AM  Edited Transcript of AMPH earnings conference call or presentation 12-Mar-19 9:00pm GMT Thomson Reuters StreetEvents
Mar-19-19 07:40AM  The Daily Biotech Pulse: FDA Nod For Roche And Amphastar, Milestone Payment Kicks In For Affimed Benzinga
06:00AM  Amphastar Pharmaceuticals Receives FDA Approval for Enoxaparin Sodium Injection 300mg/3mL (100mg/mL) Multiple Dose Vial GlobeNewswire
Mar-15-19 07:48AM  Amphastar Pharmaceuticals Inc (AMPH) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
Mar-13-19 04:17PM  This Biotech Sees Markets Worth Billions But Can It Survive A 'Pause'? Investor's Business Daily -14.44%
10:24AM  Does Market Volatility Impact Amphastar Pharmaceuticals, Inc.s (NASDAQ:AMPH) Share Price? Simply Wall St.
02:36AM  Amphastar Pharmaceuticals (AMPH) Q4 2018 Earnings Conference Call Transcript Motley Fool
Mar-12-19 07:10PM  Amphastar Pharmaceuticals (AMPH) Beats Q4 Earnings and Revenue Estimates Zacks
06:16PM  Amphastar: 4Q Earnings Snapshot Associated Press
04:05PM  Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2018 GlobeNewswire
03:00PM  Amphastar Pharmaceuticals Inc to Host Earnings Call ACCESSWIRE
07:31AM  Amphastar Pharmaceutical Q4 Earnings Preview Benzinga
Mar-08-19 09:30AM  MNK vs. AMPH: Which Stock Should Value Investors Buy Now? Zacks
Mar-07-19 04:01PM  Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12, 2019 GlobeNewswire
Feb-26-19 08:15AM  Market Trends Toward New Normal in Micron Technology, Harris, Sientra, Noble, Amphastar Pharmaceuticals, and CECO Environmental Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Feb-13-19 09:30AM  MNK vs. AMPH: Which Stock Should Value Investors Buy Now? Zacks
Jan-29-19 01:38PM  Who Has Been Selling Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares? Simply Wall St.
Jan-28-19 09:30AM  MNK vs. AMPH: Which Stock Should Value Investors Buy Now? Zacks
Jan-11-19 09:30AM  MNK vs. AMPH: Which Stock Should Value Investors Buy Now? Zacks
Jan-03-19 06:00AM  Amphastar Pharmaceuticals, Inc. Announces Launch of Primatene® MIST to Nationwide Retail Pharmacies GlobeNewswire
Dec-25-18 09:30AM  BHC vs. AMPH: Which Stock Is the Better Value Option? Zacks
Dec-23-18 09:20PM  Is Amphastar Pharmaceuticals Inc (AMPH) A Good Stock To Buy? Insider Monkey
Dec-21-18 11:04AM  How Much Did Amphastar Pharmaceuticals, Inc.s (NASDAQ:AMPH) CEO Pocket Last Year? Simply Wall St.
Dec-03-18 08:52AM  Amphastar Pharmaceuticals (AMPH) Catches Eye: Stock Jumps 6.7% Zacks
Nov-27-18 08:45AM  New Research Coverage Highlights Phibro Animal Health, RadNet, Amphastar Pharmaceuticals, FibroGen, Sientra, and Flexion Therapeutics Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Nov-22-18 09:30AM  BHC or AMPH: Which Is the Better Value Stock Right Now? Zacks
Nov-21-18 10:42AM  What You Must Know About Amphastar Pharmaceuticals Incs (NASDAQ:AMPH) Financial Strength Simply Wall St.
Nov-20-18 04:05PM  Amphastar Pharmaceuticals to Present at the 30th Annual Piper Jaffray Healthcare Conference 2018 GlobeNewswire
Nov-14-18 03:47PM  Edited Transcript of AMPH earnings conference call or presentation 8-Nov-18 10:00pm GMT Thomson Reuters StreetEvents -5.09%
Nov-09-18 06:00AM  Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference 2018 GlobeNewswire
Nov-08-18 09:32PM  Amphastar Pharmaceuticals Inc (AMPH) Q3 2018 Earnings Conference Call Transcript Motley Fool +7.58%
08:40PM  Amphastar Pharmaceuticals (AMPH) Matches Q3 Earnings Estimates Zacks
07:33PM  Amphastar: 3Q Earnings Snapshot Associated Press
04:10PM  Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2018 GlobeNewswire
Nov-07-18 09:55PM  Amphastar Pharmaceuticals, Inc. Announces Reintroduction of Primatene® MIST GlobeNewswire
Nov-06-18 04:05PM  Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2018 GlobeNewswire
09:30AM  MNK or AMPH: Which Is the Better Value Stock Right Now? Zacks
Nov-02-18 04:05PM  Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2018 GlobeNewswire
Oct-16-18 09:15AM  Consolidated Research: 2018 Summary Expectations for Freightcar America, Star Bulk Carriers, Avis Budget Group, Adamas Pharmaceuticals, Model N, and Amphastar Pharmaceuticals Fundamental Analysis, Key Performance Indications GlobeNewswire
Oct-12-18 10:18AM  Who Are The Major Shareholders In Amphastar Pharmaceuticals Inc (NASDAQ:AMPH)? Simply Wall St.
Oct-02-18 09:30AM  MNK or AMPH: Which Is the Better Value Stock Right Now? Zacks
Sep-13-18 09:30AM  AKRX vs. AMPH: Which Stock Should Value Investors Buy Now? Zacks
Aug-29-18 04:05PM  Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference 2018 GlobeNewswire
Aug-27-18 09:30AM  AKRX vs. AMPH: Which Stock Should Value Investors Buy Now? Zacks
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States and France. The company operates through two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredients products. It offers enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; naloxone for opioid overdose; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; lidocaine jelly, a local anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection for newborn babies; and morphine, atropine, calcium chloride, dextrose, epinephrine, lidocaine, and sodium bicarbonate for emergency use in hospital settings; lorazepam injection for surgery and medical procedures. In addition, it offers procainamide for documented ventricular arrhythmias; neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; medroxyprogesterone acetate injectable suspension for the prevention of pregnancy; and isoproterenol hydrochloride injection for mild or transient episodes of heart block, as well as recombinant human and porcine insulins. Further, the company has a pipeline of 20 product candidates in various stages of development for various indications. Its products are used in hospital or urgent care clinical settings, and primarily contracted and distributed through group purchasing organizations and drug wholesalers. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Petersen Floyd F.DirectorApr 01Sale14.365007,18172,142Apr 02 05:46 PM
PETERS WILLIAM JCFO, SVP & TreasurerMar 13Sale13.944,70165,53974,274Mar 17 08:07 PM
Petersen Floyd F.DirectorMar 02Sale15.565007,78272,642Mar 03 04:15 PM
Shandell Jason B.President and General CounselFeb 07Option Exercise14.406,85398,683145,751Feb 07 08:08 PM
Shandell Jason B.President and General CounselFeb 07Sale19.886,853136,260138,898Feb 07 08:08 PM
Shandell Jason B.President and General CounselFeb 06Option Exercise14.4021,933315,835160,831Feb 07 08:08 PM
Shandell Jason B.President and General CounselFeb 06Sale19.8321,933434,951138,898Feb 07 08:08 PM
Shandell Jason B.President and General CounselFeb 05Option Exercise14.4015,615224,856154,513Feb 07 08:08 PM
Shandell Jason B.President and General CounselFeb 05Sale19.5715,615305,554138,898Feb 07 08:08 PM
Petersen Floyd F.DirectorFeb 03Sale19.125009,55873,142Feb 04 04:07 PM
PETERS WILLIAM JCFO, SVP & TreasurerJan 21Sale20.073,99080,07178,975Jan 23 04:05 PM
Shandell Jason B.President and General CounselJan 08Option Exercise10.9325,000273,250163,898Jan 10 04:05 PM
Shandell Jason B.President and General CounselJan 08Sale18.4425,000460,978138,898Jan 10 04:05 PM
Petersen Floyd F.DirectorJan 02Sale19.141,00019,14273,642Jan 03 05:05 PM
Shandell Jason B.President and General CounselDec 18Sale19.138,205156,958138,898Dec 20 04:06 PM
Petersen Floyd F.DirectorDec 02Sale19.255009,62374,642Dec 04 04:06 PM
Petersen Floyd F.DirectorNov 01Sale19.485009,73875,142Nov 05 04:06 PM
Petersen Floyd F.DirectorOct 01Sale19.925009,95975,642Oct 03 06:21 PM
Shandell Jason B.President and General CounselSep 18Sale21.327,340156,509147,103Sep 20 04:05 PM
PETERS WILLIAM JCFO, SVP & TreasurerSep 16Option Exercise11.339,800111,03492,253Sep 18 04:32 PM
PETERS WILLIAM JCFO, SVP & TreasurerSep 16Sale21.769,800213,25682,453Sep 18 04:32 PM
Petersen Floyd F.DirectorSep 16Sale21.7550010,87776,142Sep 17 08:13 PM
Liawatidewi YakobSVP Corp Admin CenterSep 13Sale21.453,00064,34033,670Sep 17 07:11 PM
Zhang Jack Y.CEO & Chief Scientific OfficerSep 11Sale20.82300,0006,246,0007,027,679Sep 12 07:50 PM
Liawatidewi YakobSVP Corp Admin CenterSep 06Sale21.902,39552,4552,459Sep 09 08:16 PM
Liawatidewi YakobSVP Corp Admin CenterSep 05Sale21.241,51532,1844,854Sep 09 08:16 PM
PRINS RICHARD KDirectorAug 26Option Exercise15.113,61854,66842,927Aug 27 07:36 PM
PRINS RICHARD KDirectorAug 26Sale22.603,61881,76739,309Aug 27 07:36 PM
PRINS RICHARD KDirectorAug 23Option Exercise15.113,88258,65743,191Aug 27 07:36 PM
PRINS RICHARD KDirectorAug 23Sale22.583,88287,65439,309Aug 27 07:36 PM
PETERS WILLIAM JCFO, SVP & TreasurerAug 15Sale21.004,942103,78282,453Aug 16 05:07 PM
Liawatidewi YakobSVP Corp Admin CenterAug 13Option Exercise10.935,00054,65041,670Aug 14 05:18 PM
PRINS RICHARD KDirectorAug 13Option Exercise15.1110,000151,10049,309Aug 15 04:06 PM
PRINS RICHARD KDirectorAug 13Sale20.7810,000207,78139,309Aug 15 04:06 PM
Liawatidewi YakobSVP Corp Admin CenterAug 13Sale20.735,000103,65336,670Aug 14 05:18 PM
Liawatidewi YakobSVP Corp Admin CenterAug 12Option Exercise10.935,00054,65047,188Aug 14 05:18 PM
Liawatidewi YakobSVP Corp Admin CenterAug 12Sale20.4410,518214,96236,670Aug 14 05:18 PM
Shandell Jason B.President and General CounselJul 10Sale20.316,615134,333154,443Jul 12 07:05 PM
Zhou RongEVP, Production CenterMay 06Option Exercise20.269,600194,49666,707May 07 08:25 PM
Zhou RongEVP, Production CenterMay 06Sale22.769,600218,49657,107May 07 08:25 PM
Shandell Jason B.President and General CounselMay 01Option Exercise10.9310,000109,300169,947May 02 04:07 PM
Shandell Jason B.President and General CounselMay 01Sale21.9710,000219,700159,947May 02 04:07 PM
Shandell Jason B.President and General CounselApr 16Sale20.679,478195,879159,947Apr 18 04:05 PM
open in yahoo | open in reuters | open in google